TrademarkDir
ULEPVI
LIVE

Serial Number

97052352

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Sep 29, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ULEPVI Trademark

Serial Number: 97052352 • Registration: 7567894

ULEPVI is a trademark filed by GlaxoSmithKline Biologicals SA on September 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

September 29, 2021

Registration Date

November 19, 2024

Published for Opposition

September 3, 2024

Goods & Services

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 19, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
CASE RETURNED TO EXAMINATION
Jul 25, 2024 OTHE
NOTICE OF ALLOWANCE CANCELLED
Jul 25, 2024 IUCN
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 26, 2024 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Apr 26, 2024 PCBG
ASSIGNED TO PETITION STAFF
Apr 22, 2024 APET
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 12, 2024 EXRA
SOU EXTENSION 3 GRANTED
Apr 11, 2024 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 11, 2024 AITU
SOU EXTENSION 3 FILED
Apr 3, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 3, 2024 EEXT
TEAS PETITION TO AMEND BASIS RECEIVED
Mar 21, 2024 TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
Mar 21, 2024 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 22, 2023 EXRA
SOU EXTENSION 2 GRANTED
Sep 20, 2023 EX2G
SOU EXTENSION 2 FILED
Sep 20, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 20, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 6, 2023 EXRA
SOU EXTENSION 1 GRANTED
Apr 4, 2023 EX1G
SOU EXTENSION 1 FILED
Apr 4, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 4, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 4, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 9, 2022 PUBO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 3, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2022 REAP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 20, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2022 CNSA
ASSIGNED TO EXAMINER
Jun 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2021 NWOS
NEW APPLICATION ENTERED
Oct 2, 2021 NWAP

Related Trademarks

More from this Owner

AS04

AS04

KYDVARIX

KYDVARIX

VAXBEMVO

VAXBEMVO

EASYVAX

EASYVAX

TRUSESFLU

TRUSESFLU

VYRIXFLU

VYRIXFLU